Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics
Price for Eshop: 3647 Kč (€ 145.9)
VAT 0% included
New
E-book delivered electronically online
E-Book information
Annotation
Currently, hemoglobin (Hb)-based oxygen carriers (HBOCs) are leading candidates as red blood cell substitutes. In addition, HBOCs are also potential oxygen therapeutics for treatment of patients with critical ischemic conditions due to atherosclerosis, diabetes and other conditions. This book will provide readers a comprehensive review of topics involved in the HBOC development. It focusses on current products and clinical applications as well as on emerging technologies and future prospects.
Ask question
You can ask us about this book and we'll send an answer to your e-mail.